Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2013; 19(17): 2591-2602
Published online May 7, 2013. doi: 10.3748/wjg.v19.i17.2591
Published online May 7, 2013. doi: 10.3748/wjg.v19.i17.2591
Table 3 Summary of congenital abnormalities reported
| Congenital abnormalities (n = 19) | Affected (n) | Anti-TNF exposure |
| Ventricular septal defect | 3 | IFX (1), ADA (2) |
| Chromosomal abnormalities | 2 | IFX |
| Congenital hip dysplasia | 2 | IFX (1), ADA (1) |
| Intestinal malrotation | 1 | IFX |
| Congenital hypothyroidism | 1 | IFX |
| Hemangiomas | 1 | IFX |
| L hand polydactyly | 1 | IFX |
| Tetralogy of Fallot | 1 | IFX |
| Patent ductus arteriosus | 1 | ADA |
| Atrial septal defect and peripheral pulmonic stenosis | 1 | ADA |
| Bicuspid aortic valve and agenesis of corpus callosum | 1 | ADA |
| Primary craniosynostosis | 1 | ADA |
| Microcephaly | 1 | ADA |
| Congenital hydronephrosis | 1 | ADA |
| Undescended testes | 1 | ADA |
- Citation: Marchioni RM, Lichtenstein GR. Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review. World J Gastroenterol 2013; 19(17): 2591-2602
- URL: https://www.wjgnet.com/1007-9327/full/v19/i17/2591.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i17.2591